Members of our team had the opportunity to present a new poster abstract, "Development and Implementation of a Work Productivity and Activity Impairment Assessment Process for Employed Patients with Migraine in a Health-System Specialty Pharmacy Setting", at the NASP 2025 Annual Meeting & Expo.
Authors:
Casey Fitzpatrick, PharmD; Maria Talos, PharmD; Amanda Hickman, PharmD, MPH, MSCS; Hannah Kurtz, PharmD; Christopher Sidun, PharmD; Jedd Schlicht, PharmD; Andrew Wash, PharmD, PhD; Ana Lopez-Medina, PharmD, PhD; Ashley Zupancic, PharmD; Amber Skrtic, PharmD, CSP, AAHIVP; Jessica Mourani, PharmD
Background:
Employees diagnosed with migraine miss an average of 4.4 workdays each year and have another 11.4 reduced productivity workdays due to migraine attacks.ยน This productivity lost to migraines costs US employers billions of dollars annually.2,3
Health-system specialty pharmacy (HSSP) teams support patients in managing migraines through
ongoing monitoring of treatment effectiveness and safety, while also ensuring access to medications and promoting long-term adherence.
Although HSSP teams are well-positioned to support the clinical management of migraine, the
integration of standardized work productivity and impairment assessment tools into routine patient care workflows remains limited.
Objectives:
Read about the team's findings by downloading the outcomes study below.
1 Leonardi M, Raggi A. A narrative review on the burden of migraine: when the burden is the impact on people's life. J Headache Pain. 2019;20 (1):41. doi:10.1186/slO 194-019-0993-0
2 Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159(8):813-818. doi:10.1001/archinte.159.8.813
3 Hawkins K, WangS, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49 (4):368-37 4. doi:10.1097/ JOM.Ob013e31803b9510